converting between glp-1 agonists Metabolic Flux Adaptations During Receptor Agonist Therapy: Redox Implications | Current Obesity Reports Glucagon-Like Peptide-1: New Regulator in

Glucagon-like peptide 1 agonists, also known as GLP-1s, are a type of medicine used to treat diabetes and can also help with weight loss, according to the Mayo Clinic

All authors have reviewed the submitted version and agreed to publish the manuscript

Any alternative that produces significant weight loss, whether pharmaceutical or otherwise, carries a similar risk of telogen effluvium (temporary, diffuse hair shedding)

Benjamin Bert, MD , a board-certified ophthalmologist at MemorialCare Orange Coast Medical Center in Fountain Valley, California, added that as GLP-1s help with controlling blood sugar, their use may also lead to changes in vision prescription

2024 Jan;30(1):168-176

We therefore suggest monitoring drug levels at least at the start of cotreatment with GLP1RAs, especially in patients with kidney dysfunction who are at risk for drug accumulation to toxic levels